Introduction
Reliable access to quality-assured antiretroviral medicines is an important consideration for pharmaceutical importers, healthcare distributors, institutional procurement teams, and public-health organisations. When sourcing HIV medicines internationally, buyers need to assess product specifications, manufacturer credentials, quality documentation, regulatory status, and shipping arrangements before confirming an order.
India has an established pharmaceutical manufacturing and export industry, supplying finished medicines to international markets. For eligible buyers, Indian pharmaceutical suppliers may offer additional sourcing options, subject to product availability, manufacturing arrangements, and the regulatory requirements of the destination country.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, offers pharmaceutical products across multiple therapeutic categories. International buyers seeking dolutegravir, emtricitabine, and tenofovir alafenamide tablets can contact the company to enquire about potential sourcing options. The specific formulation, manufacturer, current availability, documentation, and export eligibility must be confirmed directly.
This article explains how international pharmaceutical buyers can evaluate suppliers, verify the exact antiretroviral combination, prepare documentation, and plan a compliant procurement process.
Key Highlights
- Generic combination: Dolutegravir, emtricitabine, and tenofovir alafenamide.
- Commonly referenced strength: 50 mg/200 mg/25 mg per tablet, respectively.
- Dosage form: Oral film-coated tablet for the referenced formulation.
- Therapeutic category: Antiretroviral combination medicine.
- Primary use: Treatment of HIV-1 infection under the applicable approved product information.
- Potential buyers: Authorised pharmaceutical importers, wholesalers, distributors, institutional procurement agencies, and eligible healthcare organisations.
- Important checks: Exact formulation, manufacturer, product registration, batch documentation, shelf life, storage, and import eligibility.
- Supplier enquiry: Contact Dolphin Pharmaceuticals to confirm whether the required product can be sourced for the intended market.
The details above refer to a specific three-drug combination. Buyers should not assume that every product containing these ingredients has the same approved indications, formulation, or regulatory status.
Understanding Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets
Dolutegravir, emtricitabine, and tenofovir alafenamide are antiretroviral medicines that act on different stages of the HIV replication process.
- Dolutegravir: An integrase strand transfer inhibitor.
- Emtricitabine: A nucleoside reverse transcriptase inhibitor.
- Tenofovir alafenamide (TAF): A nucleotide reverse transcriptase inhibitor.
When combined in an approved fixed-dose formulation, these active ingredients provide a multi-drug regimen in a single tablet. A commonly referenced presentation contains dolutegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg.
This combination is used for HIV-1 treatment under the conditions specified in the applicable product label. Eligibility depends on factors such as the approved indication, treatment history, resistance considerations, other medicines, and individual clinical circumstances.
For procurement teams, accurate product identification is essential. The requested medicine should be verified by its complete generic name, strength, dosage form, manufacturer, and approved product information.
Important product distinction: Dolutegravir/emtricitabine/tenofovir alafenamide is not the same combination as bictegravir/emtricitabine/tenofovir alafenamide. Both combinations contain emtricitabine and tenofovir alafenamide, but their integrase inhibitors differ. Buyers must verify the exact ingredients and must not treat these products as interchangeable solely because their names are similar.
Product Details for International Pharmaceutical Buyers
When requesting a quotation, buyers should establish the precise product specifications.
- Generic name: Dolutegravir, emtricitabine, and tenofovir alafenamide.
- Common fixed-dose strength: Dolutegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg per tablet.
- Dosage form: Oral film-coated tablet for the referenced presentation.
- Therapeutic category: Antiretroviral combination medicine.
- Therapeutic use: HIV-1 treatment according to the approved product information.
- Route of administration: Oral.
- Manufacturer: Confirm the actual manufacturer and manufacturing site.
- Brand name: Specify a preferred brand, if applicable.
- Packaging: Confirm available pack sizes and packaging configuration.
- Storage: Follow the approved label for the exact product supplied.
- Shelf life: Confirm the expiry date and required remaining shelf life.
- Availability: Must be verified directly with the supplier.
- Export eligibility: Depends on the product and destination-market requirements.
These specifications provide a starting point for procurement discussions. They do not confirm that Dolphin Pharmaceuticals currently stocks a particular brand or presentation.
Why Consider an Antiretroviral Medicine Supplier from India?
International pharmaceutical buyers may evaluate Indian suppliers as part of their sourcing strategy. However, supplier selection should be based on verifiable information, product suitability, documentation, and regulatory compliance rather than country of origin alone.
1. Pharmaceutical Sourcing Options
Indian pharmaceutical suppliers operate across various therapeutic categories. Depending on their product portfolios and supply arrangements, they may be able to review enquiries for specific finished medicines.
To help assess a sourcing request, buyers should provide the exact generic combination, strength, dosage form, packaging requirements, required quantity, preferred manufacturer, and destination country.
Clear specifications reduce the risk of product mismatches and support more accurate quotations.
2. Manufacturer Transparency
The exporter, distributor, and actual manufacturer may be different organisations.
Buyers should identify the company that manufactures the medicine and verify the relevant manufacturing-site details. Product labels and supporting documentation should match the medicine being offered.
Where required, buyers should also check the relevant licences and authorisations for the proposed supply arrangement.
3. Product Quality Documentation
Quality verification is an important part of pharmaceutical procurement. Buyers should request documentation appropriate to the product, manufacturer, batch, and destination market.
Depending on the transaction, relevant documents may include product specifications, batch information, a Certificate of Analysis, manufacturing details, and applicable quality certificates.
The documents should be reviewed for consistency before the shipment is approved.
4. International Supply Coordination
Cross-border pharmaceutical procurement requires coordination between the supplier, exporter, importer, logistics provider, and regulatory authorities.
Before confirming an order, buyers should discuss quotation validity, payment terms, minimum order quantities where applicable, packaging, estimated lead times, shipping arrangements, and documentation responsibilities.
Clear written terms help reduce misunderstandings during the procurement process.
Dolphin Pharmaceuticals: Pharmaceutical Sourcing Enquiries
Dolphin Pharmaceuticals is based in Surat, Gujarat, India, and offers pharmaceutical products across multiple therapeutic categories.
For buyers looking for a dolutegravir, emtricitabine and tenofovir alafenamide exporter from India, the company can be contacted to discuss the specific product requirement.
Before proceeding, buyers should request confirmation of:
- Whether the exact three-drug combination can be sourced.
- The available strength and formulation.
- Brand name and actual manufacturer.
- Manufacturing-site information, where relevant.
- Current availability and quotation.
- Packaging configuration and minimum order requirements, if applicable.
- Product and batch documentation.
- Storage and transportation requirements.
- Regulatory eligibility for the destination country.
- Estimated lead time and shipping arrangements.
A general pharmaceutical portfolio does not establish that a particular antiretroviral product is currently available. All product-specific and commercial details should be confirmed directly before an order is finalised.
How to Evaluate a Reliable Antiretroviral Medicine Exporter
Selecting a pharmaceutical exporter requires a structured review of the supplier, the medicine, and the proposed transaction.
Verify Supplier Credentials
Review the supplier's business identity, relevant licences, and role in the pharmaceutical supply chain. Establish whether the company manufactures the medicine, distributes it, or exports a product manufactured by another organisation.
Verify the authorisations relevant to the manufacturer, exporter, and importing organisation.
Confirm the Exact Formulation
Ensure that the requested product contains all three specified active ingredients.
Check the strength of each ingredient, dosage form, packaging, manufacturer, and product label. Particular care is needed to distinguish dolutegravir-based combinations from bictegravir-based combinations and other antiretroviral formulations.
Review Quality Documentation
Request the relevant product and batch documents. Verify that the generic name, strength, manufacturer, batch number, expiry information, and other applicable details are consistent.
Clarify missing information or discrepancies before approving a shipment.
Assess Storage and Transportation
Follow the storage instructions stated in the approved product information for the exact medicine.
Buyers should confirm packaging integrity, transport conditions, estimated transit time, and the minimum remaining shelf life required upon arrival.
Compare Complete Quotations
Compare quotations for the same product specification and commercial terms.
Consider the unit price, order quantity, packaging, remaining shelf life, freight, insurance where applicable, payment terms, documentation, and estimated delivery time.
A low price alone does not demonstrate product quality, authenticity, or regulatory eligibility.
Quality Documentation for Pharmaceutical Procurement
The documents required for an antiretroviral medicine transaction depend on the product, manufacturer, importing arrangement, and destination-country regulations.
Commercial Documents
Common commercial records may include:
- Proforma invoice.
- Commercial invoice.
- Packing list.
- Purchase order and agreed sales terms.
- Applicable transport documentation.
Product and Quality Documents
Depending on the transaction, buyers may need:
- Product specifications and approved product information.
- Manufacturer and manufacturing-site details.
- Batch number and expiry information.
- Certificate of Analysis, where applicable.
- Relevant manufacturing or quality certificates.
- Product registration or approval documentation, where required.
Regulatory Documents
Buyers should establish whether product registration, an import permit, importer authorisation, or other regulatory approval is required.
For institutional or public-health procurement, additional supplier qualification, product assessment, or quality-assurance requirements may apply.
Not every document applies to every product or destination. Buyers should confirm the precise requirements with the relevant authorities before shipment.
Regulatory Compliance for Global Antiretroviral Supply
Pharmaceutical exports and imports are subject to the laws and procedures of the relevant countries. A medicine's availability in India does not automatically mean it is approved for import or sale in another market.
Before confirming an order, buyers should verify:
- Whether the specific product is registered or otherwise authorised in the destination country.
- Whether an import permit or additional approval is required.
- Whether the importing organisation is authorised to receive and distribute the medicine.
- Which product, manufacturer, and quality documents must be submitted.
- Whether packaging and labelling meet local requirements.
- Whether the procurement programme has additional quality-assurance criteria.
Where WHO prequalification is a requirement, buyers should check the exact product, formulation, applicant, and manufacturing site in the relevant database. The status of one product should not be assumed to apply to another product from the same company.
Regulatory verification should take place before the order is finalised or the shipment is dispatched.
Storage, Packaging and Shipment Planning
Proper handling helps maintain product quality throughout the pharmaceutical supply chain.
Storage Requirements
Follow the manufacturer's approved storage instructions for the exact formulation. Buyers should not assume that all brands or presentations have identical temperature, humidity, or packaging requirements.
Packaging and Labelling
Confirm the pack size, packaging configuration, and labelling requirements for the destination market.
The product name, active ingredients, strength, batch information, and expiry details should be consistent with the approved product documentation.
Shelf-Life Management
Confirm the proposed batch's expiry date and the minimum remaining shelf life required by the importer.
International transit, customs clearance, and local distribution should be considered when planning the order.
Shipment Coordination
Agree on the shipping method, estimated dispatch date, transit time, and documentation responsibilities before dispatch.
The exporter, importer, and logistics provider should coordinate to ensure that the shipment follows the product's documented handling requirements.
How to Request a Quotation from Dolphin Pharmaceuticals
A clear product enquiry helps the supplier evaluate whether a suitable sourcing option may be available.
International buyers should provide:
- Exact generic combination.
- Required strength.
- Preferred brand or manufacturer, if applicable.
- Dosage form and pack size.
- Required quantity.
- Destination country.
- Known registration or import requirements.
- Required product and quality documentation.
- Preferred delivery schedule.
Buyers should request written confirmation of the product specifications, actual manufacturer, availability, commercial terms, supporting documents, and export eligibility.
The quotation should identify the exact formulation being offered so that the buyer can compare it with the original procurement requirement.
Frequently Asked Questions
1. What are dolutegravir, emtricitabine and tenofovir alafenamide tablets used for?
The combination is used for HIV-1 treatment according to the applicable approved product information. Eligibility and treatment decisions must be determined by qualified healthcare professionals.
2. What is the commonly referenced strength?
A commonly referenced fixed-dose presentation contains dolutegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg per tablet. Buyers should verify the exact product and strength required.
3. Is this combination the same as bictegravir, emtricitabine and tenofovir alafenamide?
No. The combinations have different integrase inhibitors: dolutegravir in one and bictegravir in the other. Buyers must confirm the exact ingredients and product label before procurement.
4. Can this medicine be exported from India?
International supply may be possible when the product, exporter, importer, and transaction meet applicable requirements. Availability and export eligibility must be confirmed for the specific product and destination.
5. Does Dolphin Pharmaceuticals currently stock this combination?
Current stock and sourcing availability must be confirmed directly with Dolphin Pharmaceuticals. Buyers should provide the required strength, quantity, preferred manufacturer, and destination country.
6. Which documents should buyers request?
Depending on the product and destination, buyers may need product specifications, manufacturer details, batch information, a Certificate of Analysis where applicable, quality certificates, and relevant registration or import documents.
7. Can this medicine be supplied to every international market?
No. Product registration, import permissions, importer authorisation, and procurement requirements vary by country. Buyers should verify the applicable rules before placing an order.
Conclusion
Finding a dependable dolutegravir, emtricitabine and tenofovir alafenamide exporter from India requires careful evaluation of product specifications, manufacturer credentials, quality documentation, regulatory compliance, and international logistics.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, can be contacted to discuss potential sourcing requirements for this antiretroviral combination. Buyers should confirm the exact formulation, manufacturer, current availability, supporting documentation, commercial terms, and destination-market eligibility before finalising an order.
For pharmaceutical importers, distributors, institutional procurement teams, and eligible healthcare organisations, a clear product specification and documented supplier review can support a more transparent procurement process.
Planning an antiretroviral medicine enquiry? Prepare the required strength, quantity, preferred manufacturer, destination country, and documentation requirements so that Dolphin Pharmaceuticals can assess the request and clarify the potential next steps.
Disclaimer: This article is intended for pharmaceutical procurement and general informational purposes only. Antiretroviral medicines are prescription medicines and should be supplied through authorised pharmaceutical channels. Treatment decisions must be made by qualified healthcare professionals.
My Company Name - Dolphin Pharmaceuticals
My Website - https://www.dolphinpharma.in/